VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TCMD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TCMDTactile Systems Technology, Inc.
$30.65$691M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

TCMD logoTactile Systems Technology, Inc.(TCMD)Earnings, Financials & Key Ratios

TCMD•NASDAQ
$30.65
37.4× P/E·Price updated Jul 6, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryRespiratory and sleep therapy devices
AboutTactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.Show more
  • Revenue$330M+12.5%
  • EBITDA$36M+24.0%
  • Net Income$19M+12.5%
  • EPS (Diluted)0.82+17.1%
  • Gross Margin75.17%+1.6%
  • EBITDA Margin10.9%+10.2%
  • Operating Margin8.89%+17.4%
  • Net Margin5.79%
  • ROE8.77%+6.0%

TCMD Price & Volume

Tactile Systems Technology, Inc. (TCMD) stock price & volume — 10-year historical chart

Loading chart...

Accelerating Revenue Growth Amidst Persistent Margin Volatility

Investment Thesis • Updated 2026Q1

VerdictNeutral
Growth:Accelerating
Profitability:Strained
Financial:Healthy
Cash Flow:Mixed
Primary Risk:CMS reimbursement policy volatility

Key Thesis Takeaways

  • Tactile Systems is currently navigating a transition toward accelerated top-line expansion, evidenced by a 22.8% year-over-year revenue growth in 2026Q1, though this is tempered by a high-touch sales model that currently prevents consistent operating profitability.
  • While the company has successfully deleveraged its balance sheet to a 0.07 debt-to-equity ratio, investors should monitor the ongoing impact of stock-based compensation, which frequently exceeds $1.8 million per quarter, on net income.
  • Long-term value creation remains contingent on the company's ability to scale its respiratory health segment while mitigating the inherent reimbursement friction that causes significant quarterly cash flow variance.

Verdict Logic

while the company maintains a robust 4.24 current ratio and strong 76.5% gross margins, the lack of consistent operating profitability and the volatility in quarterly cash flows warrant a cautious wait-and-see approach.

TCMD Growth Metrics

Tactile Systems Technology, Inc. (TCMD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years18.02%
5 Years11.98%
3 Years10.12%
TTM17.18%

Profit CAGR

10 Years29.92%
5 Years-
3 Years-
TTM25.33%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM33.33%

Return on Capital

10 Years4.79%
5 Years4.37%
3 Years9.74%
Last Year11.95%

TCMD Recent Earnings

Tactile Systems Technology, Inc. (TCMD) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 10/12 qtrs (83%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
May 4, 2026
Metric
Actual
Est
EPS
$0.08-14.3%
$0.07
Rev
$75M+6.7%
$71M
Q1 2026
Feb 17, 2026
Metric
Actual
Est
EPS
$0.46+4.5%
$0.44
Rev
$104M+10.4%
$94M
Q4 2025
Nov 3, 2025
Metric
Actual
Est
EPS
$0.36+125.0%
$0.16
Rev
$86M-8.6%
$94M
Q3 2025
Aug 4, 2025
Metric
Actual
Est
EPS
$0.14+55.6%
$0.09
Rev
$79M-1.2%
$80M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 4, 2026
$0.08vs $0.07-14.3%
$75Mvs $71M+6.7%
Q1 2026Feb 17, 2026
$0.46vs $0.44+4.5%
$104Mvs $94M+10.4%
Q4 2025Nov 3, 2025
$0.36vs $0.16+125.0%
$86Mvs $94M-8.6%
Q3 2025Aug 4, 2025
$0.14vs $0.09+55.6%
$79Mvs $80M-1.2%
Based on last 12 quarters of dataView full earnings history →

Latest TCMD News

Recent stock market news and headlines for Tactile Systems Technology, Inc. (TCMD)

Zacks Investment Research·Jun 29, 2026
Tactile Systems Technology (TCMD) Moves 8.1% Higher: Will This Strength Last?

Tactile Systems Technology (TCMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Peers Comparison

Key metrics vs top competitors for Tactile Systems Technology, Inc. (TCMD)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
TCMD logoTCMDTactile Systems Technology, Inc.Current
$30.65$691.35M37.3812.47%5.79%8.77%—
LNTH logoLNTHLantheus Holdings, Inc.
$102.82$6.69B30.150.5%18.05%24.33%—
ITGR logoITGRInteger Holdings Corporation
$93.40$3.21B32.327.57%7.67%8.23%—
MMSI logoMMSIMerit Medical Systems, Inc.
$71.45$4.26B33.5411.66%9.03%8.95%—
CNMD logoCNMDCONMED Corporation
$35.11$1.08B23.255.16%4%5.4%—
ATRC logoATRCAtriCure, Inc.
$32.39$1.64B-134.9614.88%-0.83%-0.95%—

Compare TCMD vs Peers

Tactile Systems Technology, Inc. (TCMD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs LNTH

Most directly comparable listed peer for TCMD.

Scale Benchmark

vs UNH

Larger-name benchmark to compare TCMD against a more recognizable public peer.

Peer Set

Compare Top 5

vs LNTH, ITGR, MMSI, CNMD

TCMD SEC Filings & Documents

Tactile Systems Technology, Inc. (TCMD) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 4, 2026·SEC

Material company update

Mar 9, 2026·SEC

Material company update

Feb 17, 2026·SEC

10-K Annual Reports

4
FY 2026

Feb 17, 2026·SEC

FY 2025

Feb 18, 2025·SEC

FY 2024

Feb 20, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 4, 2026·SEC

FY 2025

Nov 3, 2025·SEC

FY 2025

Aug 4, 2025·SEC

Get notified when TCMD posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

TCMD Frequently Asked Questions

Tactile Systems Technology, Inc. (TCMD) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Tactile Systems Technology, Inc.'s revenue?

Tactile Systems Technology, Inc. (TCMD) reported $343.5M in revenue for fiscal year 2025. This represents a 824% increase from $37.2M in 2013.

How fast is Tactile Systems Technology, Inc. growing?

Tactile Systems Technology, Inc. (TCMD) grew revenue by 12.5% over the past year. This is steady growth.

Is TCMD profitable?

Yes, Tactile Systems Technology, Inc. (TCMD) is profitable, generating $20.3M in net income for fiscal year 2025 (5.8% net margin).

Dividend & Returns
What is TCMD's return on equity?

Tactile Systems Technology, Inc. (TCMD) has a return on equity (ROE) of 8.8%. This is below average, suggesting room for improvement.

What is Tactile Systems Technology, Inc.'s free cash flow?

Tactile Systems Technology, Inc. (TCMD) generated $39.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in TCMD back in 2013?

Total return calculator · dividends reinvested · 13+ years of data

See returns →